Scancell (LON:SCLP) Stock Price Up 29.8% – Time to Buy?

Scancell Holdings plc (LON:SCLP)’s stock price rose 29.8% during mid-day trading on Monday . The stock traded as high as GBX 11.38 ($0.15) and last traded at GBX 11 ($0.15). Approximately 10,537,342 shares were traded during trading, an increase of 1,073% from the average daily volume of 897,982 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Price Performance

The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The stock’s 50-day moving average price is GBX 8.51 and its 200 day moving average price is GBX 10.85. The firm has a market cap of £103.47 million, a price-to-earnings ratio of -15.32 and a beta of 0.35.

Scancell (LON:SCLP) last released its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. Equities research analysts predict that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.